MedTrace Logo

Assessment of Implantation Potential of Embryos by Time-lapse Technology

NCT01760278 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2013-01-04

No results posted yet for this study

Summary

1. Culture conditions of developing embryos are highly controlled in the Embryoscope and are monitored by Time-lapse videography to produce 3D images at different stages.This cannot be done under conventional culture conditions.
2. The 3D images thus produced,are analysed with the help of Embryoviewer, a part of the Embryoscope,through latest software.
3. Embryoviewer also identifies embryos for transfer, freezing and to be discarded.

Conditions

  • Embryo/Fetus Death
  • Blastocyst Disintegration
  • Aneuploidy
  • Complication of Implant
  • Chemical Pregnancy

Interventions

DRUG

recombinant Follicle Stimulating Hormone (rFSH)

There are two arms of the study. The Study arm and the Control arm. In each arm, subjects, after randomization, will be stimulated with rFSH 225IU/day. On day 6, Cetrorelix 0.25mg/day to be added till the day of Ovitrell. Thereafter, ovum pick-up and embryo transfer to be done. Six weeks after transfer clinical pregnancy identified which will be the end-point of the study.

Sponsors & Collaborators

  • Padmashree Dr. D. Y. Patil Medical College

    collaborator OTHER

  • Bloom IVF and Fertility Centre

    lead OTHER

Principal Investigators

  • Hrishikesh D Pai, M.D. · Bloom IVF and Fertility Centre

  • Manchi R Bharucha, Ph.D. · Bloom IVF and Fertility Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-03-31
Completion
2013-04-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01760278 on ClinicalTrials.gov